Patents Assigned to Technology Innovation Momentum Fund (Israel) Limited Partnership
  • Publication number: 20190331942
    Abstract: An apparatus (32) includes an electronic circuit (76, 80, 84), an electro-acoustic transducer (60) and a coupler (64). The electronic circuit is configured to receive data to be transmitted over an optical cable (24), and to convert the data into a modulating signal. The electro-acoustic transducer is configured to convert the modulating signal into an acoustic wave. The coupler is mechanically coupled to a section of the optical cable, and is configured to apply to the section a longitudinal strain that varies responsively to the acoustic wave, so as to modulate the data onto an optical carrier traversing the optical cable.
    Type: Application
    Filed: June 27, 2017
    Publication date: October 31, 2019
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Avishay EYAL, Shaul OZERI
  • Publication number: 20190321422
    Abstract: Provided is a platform for of the preparation of improved nucleic acid delivery vehicles, specifically, vehicles having an extended host recognition ability. Further provided are improved vehicles, compositions and uses thereof.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 24, 2019
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Ehud QIMRON, Ido YOSEF, Moran GOREN
  • Publication number: 20190185902
    Abstract: Bacterial systems for analyzing ubiquitination of proteins is disclosed herein. Kits for analyzing the ubiquitination and methods for carrying out the analysis are also disclosed.
    Type: Application
    Filed: August 8, 2017
    Publication date: June 20, 2019
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventor: Gali PRAG
  • Publication number: 20190166699
    Abstract: Provided is a novel printing process for fabricating metallic, conductive and transparent ultra-thin nanowires and patterns including same on a substrate. The process includes two different controllable steps, each designed to achieving a useful and efficient pattern.
    Type: Application
    Filed: April 2, 2017
    Publication date: May 30, 2019
    Applicant: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: Gil MARKOVICH, Einat TIROSH, Muriel TZADKA
  • Patent number: 10245351
    Abstract: Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: April 2, 2019
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Moran Aviv, Ludmila Buzhansky, Shmuel Einav, Zvi Nevo, Ehud Gazit, Lihi Adler-Abramovich
  • Publication number: 20190092895
    Abstract: Energetic nitrogen-rich monomers represented by the general Formula I: wherein each of X1 and X2 is independently NR or a covalent bond, R is H or C1-4 alkyl, each of T1 and T2 is independently a moiety selected from the group consisting of a triazole moiety, a tetrazole moiety and a guanidine moiety, at least one of T1 and T2 being substituted by at least one polymerizable group, are disclosed herein, as well as polymers based thereon, and uses of such polymers.
    Type: Application
    Filed: November 26, 2018
    Publication date: March 28, 2019
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Michael GOZIN, Alex AIZIKOVICH, Avital SHLOMOVICH, Adva COHEN, Tali PECHERSKY
  • Patent number: 10229476
    Abstract: An imaging system color image acquisition including: an image sensor; a tunable spectral filter arranged in an optical path of light propagation towards the image sensor; and a controller connected to the image sensor and to the tunable spectral filter. The controller is configured and operable for generating a colored image by sequentially operating the tunable spectral filter for sequentially filtering light passing towards the image sensor with three or more different spectral filtering curves during three or more corresponding integration time durations. The tunable spectral filter is configured, as an etalon and includes a pair of reflective surfaces. At least one of the reflective surfaces includes a layer of high refractive index of at least n=2.3 or even higher than 3, or a layer of low refractive index, smaller than n=1.
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: March 12, 2019
    Assignee: Technology innovation momentum fund (Israel) limited partnership
    Inventors: David Mendlovic, Ariel Raz
  • Patent number: 10196477
    Abstract: Energetic nitrogen-rich monomers represented by the general Formula I: wherein each of X1 and X2 is independently NR or a covalent bond. R is H or C1-4 alkyl, each of T1 and T2 is independently a moiety selected from the group consisting of a triazole moiety, a tetrazole moiety and a guanidine moiety, at least one of T1 and T2 being substituted by at least one polymerizable group, are disclosed herein, as well as polymers based thereon, and uses of such polymers.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: February 5, 2019
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Michael Gozin, Alex Aizikovich, Avital Shlomovich, Adva Cohen, Tali Pechersky
  • Publication number: 20180177898
    Abstract: Provided are methods and formulations for imaging at least one body region of a subject, employing a glucose analog resistant or inactive to phosphrylation, or which is not a substrate for hexokinase.
    Type: Application
    Filed: March 26, 2015
    Publication date: June 28, 2018
    Applicant: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: Gil NAVON, Michal RIVLIN, Ilan TSARFATY
  • Publication number: 20180133164
    Abstract: A bioadhesive formulation, comprising gelatin, alginate and a coupling agent, capable of forming a bioadhesive matrix, which is characterized by rapid curing, optimal viscosity, high bonding strength, flexibility, biocompatibility and biodegradability, is disclosed. Further disclosed is such a bioadhesive formulation which further comprises a bioactive agent, and a drug-eluting bioadhesive matrix formed therefrom, the bioadhesive matrix being capable of delivering the bioactive agent to a bodily site. Methods utilizing the bioadhesive formulations and matrices in various biological and medical procedures are also disclosed.
    Type: Application
    Filed: December 4, 2017
    Publication date: May 17, 2018
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Meital Zilberman, Adaya Shefy-Peleg, Binyamin Cohen, Maytal Foox
  • Patent number: 9877926
    Abstract: A bioadhesive formulation, comprising gelatin, alginate and a coupling agent, capable of forming a bioadhesive matrix, which is characterized by rapid curing, optimal viscosity, high bonding strength, flexibility, biocompatibility and biodegradability, is disclosed. Further disclosed is such a bioadhesive formulation which further comprises a bioactive agent, and a drug-eluting bioadhesive matrix formed therefrom, the bioadhesive matrix being capable of delivering the bioactive agent to a bodily site. Methods utilizing the bioadhesive formulations and matrices in various biological and medical procedures are also disclosed.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: January 30, 2018
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Meital Zilberman, Adaya Shefy-Peleg, Binyamin Cohen, Maytal Foox
  • Publication number: 20170309842
    Abstract: Ordered (e.g., self-assembled) structures, arranged from peptide nucleic acids and/or analogs thereof, are disclosed. The peptide nucleic acids forming the ordered structures comprise from 1 to 10 PNA backbone units, at least one comprising a guanine nucleobase or an analog thereof. Processes of generating the ordered structures, uses thereof and articles-of manufacturing, devices and systems containing same are also disclosed.
    Type: Application
    Filed: July 13, 2017
    Publication date: October 26, 2017
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Or BERGER, Lihi ADLER-ABRAMOVICH, Ehud GAZIT
  • Patent number: 9741948
    Abstract: Ordered (e.g., self-assembled) structures, arranged from peptide nucleic acids and/or analogs thereof, are disclosed. The peptide nucleic acids forming the ordered structures comprise from 1 to 10 PNA backbone units, at least one comprising a guanine nucleobase or an analog thereof. Processes of generating the ordered structures, uses thereof and articles-of manufacturing, devices and systems containing same are also disclosed.
    Type: Grant
    Filed: May 1, 2014
    Date of Patent: August 22, 2017
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Or Berger, Lihi Adler-Abramovich, Ehud Gazit
  • Publication number: 20170226270
    Abstract: Energetic nitrogen-rich monomers represented by the general Formula I: wherein each of X1 and X2 is independently NR or a covalent bond. R is H or C1-4 alkyl, each of T1 and T2 is independently a moiety selected from the group consisting of a triazole moiety, a tetrazole moiety and a guanidine moiety, at least one of T1 and T2 being substituted by at least one polymerizable group, are disclosed herein, as well as polymers based thereon, and uses of such polymers.
    Type: Application
    Filed: October 28, 2015
    Publication date: August 10, 2017
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Michael GOZIN, Alex AIZIKOVICH, Avital SHLOMOVICH, Adva COHEN, Tali PECHERSKY
  • Publication number: 20170189582
    Abstract: Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed.
    Type: Application
    Filed: March 20, 2017
    Publication date: July 6, 2017
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Moran AVIV, Ludmila BUZHANSKY, Shmuel EINAV, Zvi NEVO, Ehud GAZIT, Lihi ADLER-ABRAMOVICH
  • Patent number: 9652827
    Abstract: An imaging system color image acquisition including: an image sensor; a tunable spectral filter arranged in an optical path of light propagation towards the image sensor; and a controller connected to the image sensor and to the tunable spectral filter. The controller is configured and operable for generating a colored image by sequentially operating the tunable spectral filter for sequentially filtering light passing towards the image sensor with three or more different spectral filtering curves during three or more corresponding integration time durations. The tunable spectral filter is configured, as an etalon and includes a pair of reflective surfaces. At least one of the reflective surfaces includes a layer of high refractive index of at least n=2.3 or even higher than 3, or a layer of low refractive index, smaller than n=1.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: May 16, 2017
    Assignee: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: David Mendlovic, Ariel Raz
  • Patent number: 9610353
    Abstract: Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed.
    Type: Grant
    Filed: July 6, 2015
    Date of Patent: April 4, 2017
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Moran Aviv, Ludmila Buzhansky, Shmuel Einav, Zvi Nevo, Ehud Gazit, Lihi Adler-Abramovich
  • Patent number: 9349935
    Abstract: Described is a superconductive layered structure and an article including this superconductive layered structure on a substrate structure. The superconductive layered structure comprises a stack including at least one bi-layered assembly formed by first and second layers of similar superconducting material compositions, the second layer being superconductive at predetermined temperature condition, the first layer being a substantially thin layer and having a c lattice parameter selected in accordance with those of the substrate structure and the second layer, such that said first layer is non-superconductive at said predetermined temperature condition thereby allowing the second superconductive layer to be desirably thick to provide high critical current density of the superconductive layer.
    Type: Grant
    Filed: February 11, 2014
    Date of Patent: May 24, 2016
    Assignee: TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP
    Inventors: Guy Deutscher, Mishael Azoulay, Boaz Almog
  • Publication number: 20150306229
    Abstract: Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed.
    Type: Application
    Filed: July 6, 2015
    Publication date: October 29, 2015
    Applicant: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Moran AVIV, Ludmila BUZHANSKY, Shmuel EINAV, Zvi NEVO, Ehud GAZIT, Lihi ADLER-ABRAMOVICH
  • Patent number: 9074095
    Abstract: Hybrid hydrogels formed of a plurality of peptides that are capable of self-assembling into a hydrogel in an aqueous solution and a biocompatible polymer that is characterized by high swelling capability, high elasticity and low mechanical strength are disclosed, with exemplary hybrid hydrogels being formed of a plurality of aromatic dipeptides and hyaluronic acid. The hybrid hydrogels are characterized by controllable mechanical and biological properties which can be adjusted by controlling the concentration ratio of the peptides and the polymer, and which average the mechanical and biological properties of the peptides and the polymer. Processes of preparing the hydrogels and uses thereof in pharmaceutical, cosmetic or cosmeceutic applications such as tissue engineering and/or regeneration are further disclosed.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: July 7, 2015
    Assignee: Technology Innovation Momentum Fund (Israel) Limited Partnership
    Inventors: Moran Aviv, Ludmila Buzhansky, Shmuel Einav, Zvi Nevo, Ehud Gazit, Lihi Adler-Abramovich